Epidemiology of chemotherapy-induced neutropenia at a tertiary university hospital in Oman

被引:5
作者
Abou Saleh, Maram [1 ]
Mafiana, Rose Ngozi [2 ]
Al Za'abi, Mohammed [1 ]
Vaishnav, Ragini [1 ]
Al Kindi, Salam [3 ]
Al-Zakwani, Ibrahim [1 ,4 ]
机构
[1] Sultan Qaboos Univ, Dept Pharmacol & Clin Pharm, Coll Med & Hlth Sci, Muscat, Oman
[2] Sultan Qaboos Univ Hosp, Dept Pharm, Muscat 123, Oman
[3] Sultan Qaboos Univ, Dept Hematol, Coll Med & Hlth Sci, Muscat, Oman
[4] Gulf Hlth Res, Muscat, Oman
关键词
Febrile neutropenia; Incidence; Length of hospital stay; Neutropenia; Oman; FEBRILE NEUTROPENIA; CANCER-PATIENTS; IMPACT;
D O I
10.1007/s11096-013-9859-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Little is known about the incidence and burden of chemotherapy-induced neutropenia (CIN) in Oman or the Arabian Gulf. Objectives To determine the epidemiology of CIN at Sultan Qaboos University Hospital in Oman. Methods A retrospective observational study of all eligible CIN episodes in adult (> 18 years) patients with solid tumors and hematological malignancies at Sultan Qaboos University Hospital (SQUH) from January to December 2010. Analyses were performed using univariate statistics. Results A total of 1,357 episodes in 159 patients with a mean age of 50 +/- A 15 years (19-91) were evaluated. Fifty-four percent (n = 86) of the patients were female. A total of 46 % (73/159) of the patients developed CIN accounting for 15 % (210/1,357) of all episodes. Twelve percent (25/210) of these CIN episodes were associated with fever in 26 % (19/73) patients. There was significant association between CIN and chemotherapy regimen (P < 0.001), younger age (P < 0.001), low hemoglobin (Hb) levels (P < 0.001) and advanced cancer stage (P = 0.006). Conclusions This study suggests a high incidence of CIN in SQUH patients which resulted in chemotherapy delays, longer hospital stays, and inpatient mortality. CIN was significantly correlated with chemotherapy regimen, younger age, low Hb levels and cancer stage.
引用
收藏
页码:1036 / 1039
页数:4
相关论文
共 50 条
  • [31] Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings
    Weycker, Derek
    Barron, Richard
    Kartashov, Alex
    Legg, Jason
    Lyman, Gary H.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (03) : 190 - 198
  • [32] Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia
    Byuk Sung Ko
    Shin Ahn
    Yoon-Seon Lee
    Won Young Kim
    Kyung Soo Lim
    Jae-Lyun Lee
    Supportive Care in Cancer, 2015, 23 : 2799 - 2804
  • [33] Colony stimulating factors for prophylaxis of chemotherapy-induced neutropenia in children
    Kim, Heeyeon
    Mousa, Shaker A.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (08) : 977 - 986
  • [34] Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia
    Ko, Byuk Sung
    Ahn, Shin
    Lee, Yoon-Seon
    Kim, Won Young
    Lim, Kyung Soo
    Lee, Jae-Lyun
    SUPPORTIVE CARE IN CANCER, 2015, 23 (09) : 2799 - 2804
  • [35] Chemotherapy Induced Neutropenia, Febrile-Neutropenia and Determinants Among Solid Cancer Patients Attending Oncology Unit of a Tertiary Care Teaching Hospital in Ethiopia
    Dessalegn, Mekonnen
    Fantahun, Mengistu
    Yesufe, Abdu Adem
    Hussein, Mintewab
    Tsegaye, Aster
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 185 - 195
  • [36] Prevention of Chemotherapy-Induced Neutropenia with Pegfilgrastim: Pharmacokinetics and Patient Outcomes
    Yang, Bing-Bing
    Savin, Michael A.
    Green, Michael
    CHEMOTHERAPY, 2012, 58 (05) : 387 - 398
  • [37] Risk models for predicting chemotherapy-induced neutropenia
    Lyman, GH
    Lyman, CH
    Agboola, O
    ONCOLOGIST, 2005, 10 (06) : 427 - 437
  • [38] Predicting the duration of chemotherapy-induced neutropenia: new scores and validation
    San Matias, S.
    Clemente, M.
    Giner-Bosch, V.
    Giner, V.
    ANNALS OF ONCOLOGY, 2011, 22 (01) : 181 - 187
  • [39] Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia
    Rofail, Pierre
    Tadros, Mariam
    Ywakim, Riham
    Tadrous, Mina
    Krug, Allison
    Cosler, Leon E.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (06) : 699 - 709
  • [40] PROTECTION FROM CHEMOTHERAPY-INDUCED NEUTROPENIA BY IMUVERT
    JIMENEZ, JJ
    HUANG, HS
    HINDAHL, M
    PEARSON, FC
    YUNIS, AA
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 303 (02) : 83 - 85